Robert Knopp

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi request reprint Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men. The Dietary Alternatives Study
    R H Knopp
    Northwest Lipid Research Clinic, Department of Medicine, University of Washington, Seattle 98104, USA
    JAMA 278:1509-15. 1997
  2. ncbi request reprint Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia
    R H Knopp
    Division of Metabolism, Endocrinology and Nutrition, Northwest Lipid Research Clinic, 325 Ninth Avenue, Room 465, Box 359720, Seattle, WA 98104, USA
    Eur Heart J 24:729-41. 2003
  3. ncbi request reprint Estrogen therapies, lipids, and the heart disease prevention controversy
    Robert H Knopp
    University of Washington, Northwest Lipid Research Clinic, 325 9th Avenue, Box 359720, Seattle, WA 98104, USA
    Curr Cardiol Rep 5:477-82. 2003
  4. doi request reprint Comprehensive lipid management versus aggressive low-density lipoprotein lowering to reduce cardiovascular risk
    Robert H Knopp
    Division of Metabolism, Endocrinology and Nutrition, Northwest Lipid Research Clinic, Seattle, Washington, USA
    Am J Cardiol 101:48B-57B. 2008
  5. ncbi request reprint Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study
    Robert H Knopp
    Northwest Lipid Research Clinic, Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98104, USA
    Metabolism 55:1697-703. 2006
  6. ncbi request reprint A moderate-fat diet for combined hyperlipidemia and metabolic syndrome
    Robert H Knopp
    Northwest Lipid Research Clinic, Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, 325 9th Avenue, Box 359720, Seattle, WA 98104, USA
    Curr Atheroscler Rep 8:492-500. 2006
  7. ncbi request reprint Treatment of hypercholesterolemia in patients with metabolic syndrome: how do different statins compare?
    Robert H Knopp
    University of Washington School of Medicine, and Division of Metabolism, Endocrinology and Nutrition, Harborview Medical Center, Seattle, WA, USA
    Nat Clin Pract Endocrinol Metab 2:136-7. 2006
  8. ncbi request reprint Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)
    Robert H Knopp
    Harborview Medical Center, 325 Ninth Ave, 359720, Seattle, WA 98104 2499, USA
    Diabetes Care 29:1478-85. 2006
  9. ncbi request reprint Gender differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease
    Robert H Knopp
    Northwest Lipid Research Clinic, University of Washington, Box 359720, Seattle, WA 98104, USA
    Curr Atheroscler Rep 7:472-9. 2005
  10. ncbi request reprint Management of patients with diabetic hyperlipidemia
    Robert H Knopp
    Northwest Lipid Research Clinic and Department of Medicine, University of Washington School of Medicine, Seattle 98104, USA
    Am J Cardiol 91:24E-28E. 2003

Research Grants

  1. NUTRITION ACADEMIC AWARD
    Robert Knopp; Fiscal Year: 2002
  2. DIETS FOR DYSLIPIDEMIA IN THE METABOLIC SYNDROME
    Robert Knopp; Fiscal Year: 2007
  3. DIETS FOR DYSLIPIDEMIA IN THE METABOLIC SYNDROME
    Robert Knopp; Fiscal Year: 2009

Detail Information

Publications53

  1. ncbi request reprint Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men. The Dietary Alternatives Study
    R H Knopp
    Northwest Lipid Research Clinic, Department of Medicine, University of Washington, Seattle 98104, USA
    JAMA 278:1509-15. 1997
    ..The long-term effect of aggressively vs moderately fat-restricted diets has not been studied extensively in free-living subjects with different types of hyperlipidemia...
  2. ncbi request reprint Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia
    R H Knopp
    Division of Metabolism, Endocrinology and Nutrition, Northwest Lipid Research Clinic, 325 Ninth Avenue, Room 465, Box 359720, Seattle, WA 98104, USA
    Eur Heart J 24:729-41. 2003
    ..This randomized, double-blind, placebo-controlled, parallel-group study evaluated the safety and efficacy of ezetimibe 10 mg/day in patients with primary hypercholesterolemia...
  3. ncbi request reprint Estrogen therapies, lipids, and the heart disease prevention controversy
    Robert H Knopp
    University of Washington, Northwest Lipid Research Clinic, 325 9th Avenue, Box 359720, Seattle, WA 98104, USA
    Curr Cardiol Rep 5:477-82. 2003
    ..quot; Until these and other points are formally addressed, the hypothesis that estrogen prevents heart disease remains open...
  4. doi request reprint Comprehensive lipid management versus aggressive low-density lipoprotein lowering to reduce cardiovascular risk
    Robert H Knopp
    Division of Metabolism, Endocrinology and Nutrition, Northwest Lipid Research Clinic, Seattle, Washington, USA
    Am J Cardiol 101:48B-57B. 2008
    ..In conclusion, 5 lines of evidence justify comprehensive diet and drug treatment for combined hyperlipidemia and, at lesser LDL elevations, the atherogenic dyslipidemias of obesity, diabetes mellitus, and the metabolic syndrome...
  5. ncbi request reprint Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study
    Robert H Knopp
    Northwest Lipid Research Clinic, Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98104, USA
    Metabolism 55:1697-703. 2006
    ..54). In conclusion, in the short term, colesevelam HCl may not consistently add cholesterol-lowering benefit to ezetimibe. This observation requires confirmation...
  6. ncbi request reprint A moderate-fat diet for combined hyperlipidemia and metabolic syndrome
    Robert H Knopp
    Northwest Lipid Research Clinic, Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, 325 9th Avenue, Box 359720, Seattle, WA 98104, USA
    Curr Atheroscler Rep 8:492-500. 2006
    ..A test of this dietary strategy on lipoproteins and downstream benefits on inflammatory mediators, oxidative stress, and vascular reactivity is now underway...
  7. ncbi request reprint Treatment of hypercholesterolemia in patients with metabolic syndrome: how do different statins compare?
    Robert H Knopp
    University of Washington School of Medicine, and Division of Metabolism, Endocrinology and Nutrition, Harborview Medical Center, Seattle, WA, USA
    Nat Clin Pract Endocrinol Metab 2:136-7. 2006
  8. ncbi request reprint Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)
    Robert H Knopp
    Harborview Medical Center, 325 Ninth Ave, 359720, Seattle, WA 98104 2499, USA
    Diabetes Care 29:1478-85. 2006
    ..The purpose of this study was to assess the effect of 10 mg of atorvastatin versus placebo on CVD prevention in subjects with type 2 diabetes and LDL cholesterol levels below contemporary guideline targets...
  9. ncbi request reprint Gender differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease
    Robert H Knopp
    Northwest Lipid Research Clinic, University of Washington, Box 359720, Seattle, WA 98104, USA
    Curr Atheroscler Rep 7:472-9. 2005
    ..Dietary fat restriction in women appears to have a less beneficial lipoprotein effect than in men. Dietary fat restriction for heart disease prevention may be less ideal in women than in men...
  10. ncbi request reprint Management of patients with diabetic hyperlipidemia
    Robert H Knopp
    Northwest Lipid Research Clinic and Department of Medicine, University of Washington School of Medicine, Seattle 98104, USA
    Am J Cardiol 91:24E-28E. 2003
    ..We also present a case study of a diabetic woman with hyperlipidemia and coronary artery disease...
  11. ncbi request reprint One-year effects of increasingly fat-restricted, carbohydrate-enriched diets on lipoprotein levels in free-living subjects
    R H Knopp
    Northwest Lipid Research Clinic and the Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington 98104, USA
    Proc Soc Exp Biol Med 225:191-9. 2000
    ..The HDL-C decrease in HC women may have a similar cause and points to an underlying male-female difference. Alternative dietary approaches to limit saturated fat intake deserve intensive study...
  12. ncbi request reprint Effects of insulin resistance and obesity on lipoproteins and sensitivity to egg feeding
    Robert H Knopp
    University of Washington, Northwest Lipid Research Clinic, Seattle, Wash 98104, USA
    Arterioscler Thromb Vasc Biol 23:1437-43. 2003
    ..This study was undertaken to determine if insulin resistance without and with obesity influences LDL response to dietary cholesterol and saturated fat...
  13. ncbi request reprint Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel
    R H Knopp
    Northwest Lipid Research Clinic in the Department of Medicine, University of Washington, Seattle, USA
    Contraception 63:1-11. 2001
    ..The lipoprotein, SHBG, and protein S and factor V differences are likely due to the lesser androgenicity of DSG allowing for a greater expression of the dose of estrogen...
  14. ncbi request reprint The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : distinct metabolic effects of two fat compartments
    Miriam Cnop
    Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, VA Puget Sound Health Care System, and Harborview Medical Center, Seattle, Washington 98108, USA
    Diabetes 51:1005-15. 2002
    ....
  15. pmc Combined hyperlipidemia in relation to race/ethnicity, obesity, and insulin resistance in the Multi-Ethnic Study of Atherosclerosis
    Pathmaja Paramsothy
    Department of Internal Medicine Division of Cardiology, University of Washington, Seattle, WA 98105, USA
    Metabolism 58:212-9. 2009
    ..Further research is needed to determine the most efficacious diet, exercise, and drug management to decrease the risk of CHL and coronary heart disease among racial/ethnic groups in the United States...
  16. pmc HDL in humans with cardiovascular disease exhibits a proteomic signature
    Tomas Vaisar
    Department of Medicine, School of Medicine, University of Washington, Seattle, Washington 98195, USA
    Clin Chim Acta 411:972-9. 2010
    ..We tested whether relative levels of proteins in HDL(2) could be used as biomarkers for coronary artery disease (CAD)...
  17. ncbi request reprint Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses
    Kristina M Utzschneider
    Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, VA Puget Sound Health Care System 151, 1660 S Columbian Way, Seattle, WA 98108, USA
    Diabetes Care 29:356-62. 2006
    ..To determine whether the hyperbolic relationship between insulin sensitivity and the acute insulin response to glucose (AIRg) exists in subjects with impaired fasting glucose (IFG) or decreased glucose tolerance...
  18. doi request reprint Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis)
    Pathmaja Paramsothy
    Division of Cardiology, Department of Internal Medicine, University of Washington, Seattle, Washington 98104, USA
    J Am Coll Cardiol 56:1034-41. 2010
    ..The purpose of this study was to determine the association of combinations of lipid parameters with subclinical atherosclerosis...
  19. pmc Combined statin and niacin therapy remodels the high-density lipoprotein proteome
    Pattie S Green
    Department of Medicine, University of Washington, Seattle, WA, USA
    Circulation 118:1259-67. 2008
    ..We hypothesized that an intervention that increases HDL levels-combined statin and niacin therapy-might reverse these changes...
  20. ncbi request reprint Relationship of liver enzymes to insulin sensitivity and intra-abdominal fat
    Tara M Wallace
    Department of Medicine, VA Puget Sound Health Care System, and University of Washington, Seattle, WA 98108, USA
    Diabetes Care 30:2673-8. 2007
    ..The purpose of this study was to determine the relationship between plasma liver enzyme concentrations, insulin sensitivity, and intra-abdominal fat (IAF) distribution...
  21. pmc Endogenous red blood cell membrane fatty acids and sudden cardiac arrest
    Rozenn N Lemaitre
    Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA 98101, USA
    Metabolism 59:1029-34. 2010
    ..Further work is needed to investigate if conditions that favor de novo fatty acid synthesis, such as high-carbohydrate/low-fat diets, might also increase the risk of SCA...
  22. pmc Red blood cell membrane alpha-linolenic acid and the risk of sudden cardiac arrest
    Rozenn N Lemaitre
    Department of Medicine, University of Washington, Seattle, WA 98101, USA
    Metabolism 58:534-40. 2009
    ..The association was independent of red blood cell levels of long-chain n-3 fatty acids, trans-fatty acids, and linoleic acid. Higher membrane levels of alpha-linolenic acid are associated with higher risk of sudden cardiac arrest...
  23. pmc Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia
    Andrew N Hoofnagle
    Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA
    Arterioscler Thromb Vasc Biol 30:2528-34. 2010
    ..To determine whether obesity and insulin resistance associate with changes in the protein content of high-density lipoprotein (HDL) in 2 different groups of men by using targeted proteomics...
  24. ncbi request reprint Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome
    Darcy B Carr
    Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington 98195 6460, USA
    Diabetes 53:2087-94. 2004
    ..Of the NCEP criteria, waist circumference and triglycerides may best identify insulin resistance and visceral adiposity in individuals with a fasting plasma glucose <6.4 mmol/l...
  25. ncbi request reprint Cell membrane trans-fatty acids and the risk of primary cardiac arrest
    Rozenn N Lemaitre
    Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle 98101, USA
    Circulation 105:697-701. 2002
    ..The relation of trans-fatty acid intake to life-threatening arrhythmias and primary cardiac arrest is unknown...
  26. ncbi request reprint Norgestimate and medroxyprogesterone acetate do not attenuate the atheroprotective effects of 17beta-estradiol in ovariectomized, apolipoprotein E-deficient mice
    Jennifer M Shultz
    Interdisciplinary Graduate Program in Nutritional Sciences, University of Washington, Seattle 98195, USA
    Fertil Steril 82:1133-9. 2004
    ..To determine whether progestins counteract the cardioprotective effects of estrogen...
  27. ncbi request reprint The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat
    Delma J Nieves
    Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, Veterans Affairs Puget Sound Health Care System and Harborview Medical Center, University of Washington, Seattle, Washington 98108, USA
    Diabetes 52:172-9. 2003
    ..Thus an atherogenic lipoprotein profile appears to be the result primarily of an increase in IAF, perhaps via insulin resistance...
  28. ncbi request reprint Impact of intra-abdominal fat and age on insulin sensitivity and beta-cell function
    Kristina M Utzschneider
    Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, Veterans Affairs Puget Sound Health Care System 151, 1660 S Columbian Way, Seattle, WA 98108, USA
    Diabetes 53:2867-72. 2004
    ....
  29. ncbi request reprint Low-density lipoprotein inhibits secretion of phospholipid transfer protein in human trophoblastic BeWo cells
    An Yue Tu
    Department of Medicine, Northwest Lipid Research Laboratories, Northwest Lipid Research Clinic, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, 2121 N 35th Street, Seattle, WA 98103, USA
    Exp Biol Med (Maywood) 229:1046-52. 2004
    ..These results support the conclusion that LDL-mediated suppression of PLTP secretion in BeWo cells is through a LDL receptor-independent MAPK signaling pathway...
  30. pmc Management of dyslipidaemias
    Pathmaja Paramsothy
    Division of Cardiology, University of Washington Harborview Medical Center, Seattle, Washngton 98104, USA
    Heart 92:1529-34. 2006
  31. doi request reprint Improving insulin ordering safely: the development of an inpatient glycemic control program
    Rachel Thompson
    Division of General Internal Medicine, Harborview Medical Center, University of Washington, Seattle, Washington 98104, USA
    J Hosp Med 4:E30-5. 2009
    ..003). Distinguishing characteristics of this Glycemic Control Program include the use of real-time data to identify patients with out-of-range glucoses and the employment of a single clinician to cover all non-critical care floors...
  32. ncbi request reprint Enhancing recruitment of healthy African American volunteers in a city with a small African American community: results from a dietary supplement crossover trial
    Cheryl A M Anderson
    Department of Epidemiology, University of Washington, USA
    Ethn Dis 17:555-9. 2007
    ..To describe strategies for enhancing recruitment of African Americans to a longterm intervention study requiring frequent blood draws and follow-up visits, in a city with relatively few African Americans...
  33. ncbi request reprint Physician informational needs in providing nutritional guidance to patients
    Tanis V Mihalynuk
    Interdisciplinary Nutritional Sciences Program, School of Public Health and Community Medicine, University of Washington, Seattle 98195, USA
    Fam Med 36:722-6. 2004
    ..This study's objective was to assess patient nutrition inquiries and related physician resources to identify the nutrition topics about which physicians most need information for patients and practice...
  34. ncbi request reprint Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects
    Lisa R Tannock
    Department of Medicine, University of Washington, 1959 NE Pacific St, Seattle, WA 98195 6426, USA
    Circulation 111:3058-62. 2005
    ..Inflammatory markers associated with elevated cardiovascular risk are increased by cholesterol feeding in animal models. However, whether dietary cholesterol increases inflammatory marker levels in humans is not known...
  35. pmc Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL
    Tomas Vaisar
    Department of Medicine, University of Washington School of Medicine, Seattle, Washington 98195, USA
    J Clin Invest 117:746-56. 2007
    ....
  36. ncbi request reprint Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy: evidence for a protective adaptation in diabetes
    Lois Jovanovic
    University of Washington, 325 Ninth Ave, Box 359720, Seattle, WA 98104, USA
    Diabetes Care 28:1113-7. 2005
    ..To test this hypothesis, we examined relationships of proximate measures of prior glycemia, glycated protein and fructosamine, to pregnancy loss...
  37. ncbi request reprint Association of lung function with atherosclerotic risk factors among Japanese Americans: Seattle Nikkei Health Study
    Kenichiro Taneda
    Department of Medicine, University of Washington, Washington, USA
    Clin Exp Pharmacol Physiol 31:S31-4. 2004
    ..However, our findings imply that light and moderate drinking may be a protective factor of lung function and that hypertension and smoking may impair lung function...
  38. ncbi request reprint Risk factors for coronary artery disease in women
    Robert H Knopp
    Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, Washington 98104, USA
    Am J Cardiol 89:28E-34E; discussion 34E-35E. 2002
    ..Because of the complex origin of CVD, it is important to target the full array of risk factors for modification, rather than focusing on a single factor or treatment to the exclusion of other important markers...
  39. ncbi request reprint Survey correlations: proficiency and adequacy of nutrition training of medical students
    Tanis V Mihalynuk
    Interdisciplinary Nutritional Sciences Program, University of Washington, Seattle, Washington, USA
    J Am Coll Nutr 27:59-64. 2008
    ....
  40. pmc Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program
    Allan F Moore
    Center for Human Genetic Research, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
    Diabetes 57:2503-10. 2008
    ....
  41. ncbi request reprint Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study)
    James M McKenney
    National Clinical Research, Richmond, VA 23227, United States
    Atherosclerosis 192:432-7. 2007
    ..No drug-related myopathy or hepatotoxicity was observed. In this study, low to moderate dose combination therapy with a statin and niacin ER provided broad control of lipids and lipoproteins independently associated with CHD...
  42. ncbi request reprint Effect of raloxifene on serum triglycerides in women with a history of hypertriglyceridemia while on oral estrogen therapy
    Molly C Carr
    Division of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611 3008, USA
    Diabetes Care 28:1555-61. 2005
    ..This study was designed to assess the effect of raloxifene on serum triglycerides in postmenopausal women who have a history of increased hypertriglyceridemia with oral estrogen therapy...
  43. ncbi request reprint Oxidized LDL and abdominal obesity: a key to understanding the metabolic syndrome
    Robert H Knopp
    Am J Clin Nutr 83:1-2. 2006
  44. ncbi request reprint Undesirable effects of extreme dietary carbohydrate and saturated fat intakes: the search for the middle ground
    Robert H Knopp
    Curr Atheroscler Rep 7:409-11. 2005
  45. ncbi request reprint Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease
    Dennis W Schneck
    AstraZeneca LP, Wilmington, Delaware 19850 5437, USA
    Am J Cardiol 91:33-41. 2003
    ..Significantly greater triglyceride decreases were seen at 80 mg with atorvastatin over rosuvastatin. Both rosuvastatin and atorvastatin were well tolerated over 6 weeks...
  46. ncbi request reprint Strategies for reducing cardiovascular risk in patients with hypertriglyceridemia
    Janet U Gorkin
    Albert Einstein College of Medicine, Bronx, NY USA
    J Fam Pract 56:S1-7; quiz S8. 2007
  47. ncbi request reprint Estrogens, lipoproteins, and cardiovascular risk factors: an update following the randomized placebo-controlled trials of hormone-replacement therapy
    Mary Seed
    Department of Cardiology, Charing Cross Hospital, London, W6 8RF, UK
    Curr Opin Lipidol 15:459-67. 2004
    ..In an attempt to explain the results of recent randomized controlled trials in which no benefit of hormone-replacement therapy for postmenopausal women has been observed,..
  48. ncbi request reprint Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study
    Richard H Karas
    Division of Cardiology, Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts, USA
    Am J Cardiovasc Drugs 8:69-81. 2008
    ..This fact has focused increased attention on treating abnormalities of non-high-density lipoprotein-cholesterol (non-HDL-C), HDL-C, and triglycerides in national guidelines and has intensified interest in combination therapy...
  49. pmc Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care
    John L Kitzmiller
    Division of Maternal Fetal Medicine, Santa Clara Valley Medical Center, San Jose, California 95128, USA
    Diabetes Care 31:1060-79. 2008
  50. ncbi request reprint Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS)
    Michael G Shlipak
    General Internal Medicine Section, Veterans Affairs Medical Center, San Francisco, Calif 94121, USA
    Am Heart J 146:870-5. 2003
    ..To explore possible mechanisms, we examined the association between lipid changes and CHD outcomes among women assigned to hormone therapy...
  51. ncbi request reprint Saturated fat prevents coronary artery disease? An American paradox
    Robert H Knopp
    Am J Clin Nutr 80:1102-3. 2004
  52. ncbi request reprint Gestational diabetes and the incidence of type 2 diabetes: a systematic review
    Catherine Kim
    Division of General Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA
    Diabetes Care 25:1862-8. 2002
    ..To examine factors associated with variation in the risk for type 2 diabetes in women with prior gestational diabetes mellitus (GDM)...
  53. ncbi request reprint John B. O'Sullivan: a pioneer in the study of gestational diabetes
    Robert H Knopp
    Diabetes Care 25:943-4. 2002

Research Grants4

  1. NUTRITION ACADEMIC AWARD
    Robert Knopp; Fiscal Year: 2002
    ..It is time to begin aggressive, substantive nutrition educational programs in cardiovascular disease prevention. ..
  2. DIETS FOR DYSLIPIDEMIA IN THE METABOLIC SYNDROME
    Robert Knopp; Fiscal Year: 2007
    ..This study will be the first to demonstrate dietary benefit for dyslipidemia, inflammation and vascular stress in MetS at stable weight. ..
  3. DIETS FOR DYSLIPIDEMIA IN THE METABOLIC SYNDROME
    Robert Knopp; Fiscal Year: 2009
    ..This study will be the first to demonstrate dietary benefit for dyslipidemia, inflammation and vascular stress in MetS at stable weight. ..